JP2022532213A5 - - Google Patents
Info
- Publication number
- JP2022532213A5 JP2022532213A5 JP2021568011A JP2021568011A JP2022532213A5 JP 2022532213 A5 JP2022532213 A5 JP 2022532213A5 JP 2021568011 A JP2021568011 A JP 2021568011A JP 2021568011 A JP2021568011 A JP 2021568011A JP 2022532213 A5 JP2022532213 A5 JP 2022532213A5
- Authority
- JP
- Japan
- Prior art keywords
- process according
- mrna
- lipid
- solution
- lipids
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025034187A JP2025084968A (ja) | 2019-05-14 | 2025-03-05 | Mrna担持脂質ナノ粒子を調製する改善されたプロセス |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962847837P | 2019-05-14 | 2019-05-14 | |
| US62/847,837 | 2019-05-14 | ||
| PCT/US2020/032943 WO2020232276A1 (en) | 2019-05-14 | 2020-05-14 | Improved process of preparing mrna-loaded lipid nanoparticles |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025034187A Division JP2025084968A (ja) | 2019-05-14 | 2025-03-05 | Mrna担持脂質ナノ粒子を調製する改善されたプロセス |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022532213A JP2022532213A (ja) | 2022-07-13 |
| JP2022532213A5 true JP2022532213A5 (cg-RX-API-DMAC10.html) | 2023-05-22 |
| JP7707080B2 JP7707080B2 (ja) | 2025-07-14 |
Family
ID=70919274
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021568011A Active JP7707080B2 (ja) | 2019-05-14 | 2020-05-14 | Mrna担持脂質ナノ粒子を調製する改善されたプロセス |
| JP2025034187A Pending JP2025084968A (ja) | 2019-05-14 | 2025-03-05 | Mrna担持脂質ナノ粒子を調製する改善されたプロセス |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025034187A Pending JP2025084968A (ja) | 2019-05-14 | 2025-03-05 | Mrna担持脂質ナノ粒子を調製する改善されたプロセス |
Country Status (12)
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MA49421A (fr) | 2017-06-15 | 2020-04-22 | Modernatx Inc | Formulations d'arn |
| MX2020002348A (es) | 2017-08-31 | 2020-10-08 | Modernatx Inc | Métodos de elaboración de nanopartículas lipídicas. |
| US12090235B2 (en) | 2018-09-20 | 2024-09-17 | Modernatx, Inc. | Preparation of lipid nanoparticles and methods of administration thereof |
| DK3864163T3 (da) | 2018-10-09 | 2024-05-06 | Univ British Columbia | Sammensætninger og systemer omfattende transfektionskompetente vesikler fri for organiske opløsningsmidler og rengøringsmidler og fremgangsmåder forbundet dermed |
| CN113939282A (zh) | 2019-01-31 | 2022-01-14 | 摩登纳特斯有限公司 | 制备脂质纳米颗粒的方法 |
| US12678406B2 (en) | 2020-10-12 | 2026-07-14 | Translate Bio Inc. | Process of preparing ice-based lipid nanoparticles |
| CA3198411A1 (en) * | 2020-10-12 | 2022-04-21 | Translate Bio, Inc. | Improved process of preparing mrna-loaded lipid nanoparticles |
| MX2023004371A (es) * | 2020-10-14 | 2023-07-26 | George Mason Res Foundation Inc | Lípidos ionizables, y métodos de fabricación y uso de los mismos. |
| EP4763287A2 (en) | 2021-09-03 | 2026-06-24 | CureVac SE | Novel lipid nanoparticles for delivery of nucleic acids |
| CN115745815B (zh) * | 2021-09-03 | 2025-06-10 | 广州谷森制药有限公司 | 阳离子脂质化合物 |
| EP4422698A1 (en) | 2021-10-29 | 2024-09-04 | CureVac SE | Improved circular rna for expressing therapeutic proteins |
| KR102772764B1 (ko) * | 2021-11-10 | 2025-02-27 | 주식회사 에스엠엘바이오팜 | 트레할로즈 유도체 및 신규 구조 유지 화합물을 포함하는 핵산 의약품 전달용 지질나노입자의 약학 조성물 |
| WO2023092151A1 (en) * | 2021-11-22 | 2023-05-25 | Ohio State Innovation Foundation | Compositions and methods for the treatment of neurodegenerative disorders |
| EP4469091A1 (en) | 2022-01-28 | 2024-12-04 | CureVac SE | Nucleic acid encoded transcription factor inhibitors |
| CA3248209A1 (en) | 2022-05-25 | 2023-11-30 | CureVac SE | Escherichia coli Antigenic Polypeptide-Based Nucleic Acid Vaccine (FIMH) |
| JP2023181989A (ja) * | 2022-06-13 | 2023-12-25 | 上海臻上医薬科技有限公司 | マイクロニードル注射製剤およびその使用 |
| WO2024089638A1 (en) | 2022-10-28 | 2024-05-02 | Glaxosmithkline Biologicals Sa | Nucleic acid based vaccine |
| KR20250153298A (ko) | 2023-03-08 | 2025-10-24 | 큐어백 에스이 | 핵산 전달을 위한 신규의 지질 나노입자 제형 |
| WO2024230934A1 (en) | 2023-05-11 | 2024-11-14 | CureVac SE | Therapeutic nucleic acid for the treatment of ophthalmic diseases |
| WO2026033123A1 (en) | 2024-08-08 | 2026-02-12 | Sanofi Pasteur Inc. | Lipid nanoparticle formulations for mrna delivery |
Family Cites Families (35)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4500707A (en) | 1980-02-29 | 1985-02-19 | University Patents, Inc. | Nucleosides useful in the preparation of polynucleotides |
| US5132418A (en) | 1980-02-29 | 1992-07-21 | University Patents, Inc. | Process for preparing polynucleotides |
| US4458066A (en) | 1980-02-29 | 1984-07-03 | University Patents, Inc. | Process for preparing polynucleotides |
| US4415732A (en) | 1981-03-27 | 1983-11-15 | University Patents, Inc. | Phosphoramidite compounds and processes |
| US4973679A (en) | 1981-03-27 | 1990-11-27 | University Patents, Inc. | Process for oligonucleo tide synthesis using phosphormidite intermediates |
| US4668777A (en) | 1981-03-27 | 1987-05-26 | University Patents, Inc. | Phosphoramidite nucleoside compounds |
| US4373071A (en) | 1981-04-30 | 1983-02-08 | City Of Hope Research Institute | Solid-phase synthesis of polynucleotides |
| US4401796A (en) | 1981-04-30 | 1983-08-30 | City Of Hope Research Institute | Solid-phase synthesis of polynucleotides |
| US4897355A (en) | 1985-01-07 | 1990-01-30 | Syntex (U.S.A.) Inc. | N[ω,(ω-1)-dialkyloxy]- and N-[ω,(ω-1)-dialkenyloxy]-alk-1-yl-N,N,N-tetrasubstituted ammonium lipids and uses therefor |
| US5153319A (en) | 1986-03-31 | 1992-10-06 | University Patents, Inc. | Process for preparing polynucleotides |
| US5047524A (en) | 1988-12-21 | 1991-09-10 | Applied Biosystems, Inc. | Automated system for polynucleotide synthesis and purification |
| US5262530A (en) | 1988-12-21 | 1993-11-16 | Applied Biosystems, Inc. | Automated system for polynucleotide synthesis and purification |
| FR2645866B1 (fr) | 1989-04-17 | 1991-07-05 | Centre Nat Rech Scient | Nouvelles lipopolyamines, leur preparation et leur emploi |
| US5334761A (en) | 1992-08-28 | 1994-08-02 | Life Technologies, Inc. | Cationic lipids |
| US5700642A (en) | 1995-05-22 | 1997-12-23 | Sri International | Oligonucleotide sizing using immobilized cleavable primers |
| US5744335A (en) | 1995-09-19 | 1998-04-28 | Mirus Corporation | Process of transfecting a cell with a polynucleotide mixed with an amphipathic compound and a DNA-binding protein |
| CA2569664C (en) | 2004-06-07 | 2013-07-16 | Protiva Biotherapeutics, Inc. | Lipid encapsulated interfering rna |
| AU2009303345B2 (en) | 2008-10-09 | 2015-08-20 | Arbutus Biopharma Corporation | Improved amino lipids and methods for the delivery of nucleic acids |
| WO2010053572A2 (en) | 2008-11-07 | 2010-05-14 | Massachusetts Institute Of Technology | Aminoalcohol lipidoids and uses thereof |
| SI2506857T1 (en) | 2009-12-01 | 2018-08-31 | Translate Bio, Inc. | Delivery of mRNA for the enrichment of proteins and enzymes in human genetic diseases |
| EP4074693A1 (en) | 2011-06-08 | 2022-10-19 | Translate Bio, Inc. | Cleavable lipids |
| KR20220025112A (ko) | 2011-06-08 | 2022-03-03 | 샤이어 휴먼 지네틱 테라피즈 인크. | Mrna 전달을 위한 지질 나노입자 조성물 및 방법 |
| US9512073B2 (en) | 2011-10-27 | 2016-12-06 | Massachusetts Institute Of Technology | Amino acid-, peptide-and polypeptide-lipids, isomers, compositions, and uses thereof |
| ES2967701T3 (es) * | 2013-03-15 | 2024-05-03 | Translate Bio Inc | Mejora sinergística de la entrega de ácidos nucleicos mediante formulaciones mezcladas |
| WO2015184256A2 (en) | 2014-05-30 | 2015-12-03 | Shire Human Genetic Therapies, Inc. | Biodegradable lipids for delivery of nucleic acids |
| WO2016004318A1 (en) * | 2014-07-02 | 2016-01-07 | Shire Human Genetic Therapies, Inc. | Encapsulation of messenger rna |
| WO2016118724A1 (en) | 2015-01-21 | 2016-07-28 | Moderna Therapeutics, Inc. | Lipid nanoparticle compositions |
| EP3247398A4 (en) | 2015-01-23 | 2018-09-26 | Moderna Therapeutics, Inc. | Lipid nanoparticle compositions |
| RS63051B1 (sr) | 2015-12-22 | 2022-04-29 | Modernatx Inc | Jedinjenja i kompozicije za intracelularnu isporuku agenasa |
| EP3442590A2 (en) | 2016-04-13 | 2019-02-20 | Modernatx, Inc. | Lipid compositions and their uses for intratumoral polynucleotide delivery |
| AU2017283479B2 (en) | 2016-06-13 | 2023-08-17 | Translate Bio, Inc. | Messenger RNA therapy for the treatment of ornithine transcarbamylase deficiency |
| US20180153822A1 (en) * | 2016-11-10 | 2018-06-07 | Translate Bio, Inc. | Process of Preparing mRNA-Loaded Lipid Nanoparticles |
| CA3077391A1 (en) * | 2017-09-29 | 2019-04-04 | Intellia Therapeutics, Inc. | In vitro method of mrna delivery using lipid nanoparticles |
| CN118436618A (zh) * | 2018-05-30 | 2024-08-06 | 川斯勒佰尔公司 | 信使rna疫苗及其用途 |
| US20220016265A1 (en) * | 2018-11-09 | 2022-01-20 | Translate Bio, Inc. | Messenger rna therapy for treatment of ocular diseases |
-
2020
- 2020-05-14 AU AU2020274758A patent/AU2020274758B2/en active Active
- 2020-05-14 CN CN202080049849.1A patent/CN114126588A/zh active Pending
- 2020-05-14 EP EP20729587.4A patent/EP3968952A1/en active Pending
- 2020-05-14 MX MX2021013959A patent/MX2021013959A/es unknown
- 2020-05-14 SG SG11202112574RA patent/SG11202112574RA/en unknown
- 2020-05-14 WO PCT/US2020/032943 patent/WO2020232276A1/en not_active Ceased
- 2020-05-14 US US17/611,020 patent/US20220218612A1/en active Pending
- 2020-05-14 CA CA3140423A patent/CA3140423A1/en active Pending
- 2020-05-14 KR KR1020217040794A patent/KR20220024022A/ko not_active Ceased
- 2020-05-14 JP JP2021568011A patent/JP7707080B2/ja active Active
- 2020-05-14 BR BR112021022909A patent/BR112021022909A2/pt unknown
-
2021
- 2021-11-11 IL IL288020A patent/IL288020A/en unknown
-
2025
- 2025-03-05 JP JP2025034187A patent/JP2025084968A/ja active Pending
- 2025-07-28 AU AU2025208550A patent/AU2025208550A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2025084968A5 (cg-RX-API-DMAC10.html) | ||
| JP7758717B2 (ja) | ビタミンカチオン性脂質 | |
| US12102720B2 (en) | Cleavable lipids | |
| JP7764363B2 (ja) | mRNA担持脂質ナノ粒子の安定性組成物および作製のプロセス | |
| JP7586886B2 (ja) | 改善されたmRNA装填脂質ナノ粒子、およびそれを作製するプロセス | |
| EP3628335B1 (en) | Lipidic nanoparticles for mrna delivery in the lungs | |
| US20220218612A1 (en) | Improved process of preparing mrna-loaded lipid nanoparticles | |
| US20190185435A1 (en) | Stereochemically enriched compositions for delivery of nucleic acids | |
| JP2019533707A5 (cg-RX-API-DMAC10.html) | ||
| JP2022512945A (ja) | 層間エステル、チオエステル、ジスルフィドおよび無水部分を含む2,5-ジオキソピペラジン脂質 | |
| JP2024513048A5 (cg-RX-API-DMAC10.html) | ||
| WO2024153098A1 (zh) | 脂质化合物和脂质纳米颗粒组合物 | |
| RU2021136653A (ru) | УЛУЧШЕННЫЙ СПОСОБ ПОЛУЧЕНИЯ ЛИПИДНЫХ НАНОЧАСТИЦ, ЗАГРУЖЕННЫХ мРНК | |
| HK40082296A (en) | Cleavable lipids | |
| HK1196964A (en) | Cleavable lipids | |
| HK1196964B (en) | Cleavable lipids |